HSK36273

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HSK36273, covering 2022-11-02 to 2022-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects [Phase 2]

See pricing